IPG vs MDGL
IPG (IPG) versus Madrigal Pharmaceuticals Inc (MDGL) — a side-by-side from cached financials, not a winner call.
IPG (IPG) common stock.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
IPG does not have a complete income-statement cache yet.
Latest reported MDGL revenue for 2024-12-31 was $180.1M. Net income was -$465.9M. MDGL currently screens at market cap $11.56B.
MDGL currently screens at market cap $11.56B.
Not investment advice. Open the IPG and MDGL stock pages for the full models.
Not investment advice.